Effects of loss of p53 and p16 function on life span and survival of human urothelial cells

Nicola J. Shaw, Nikolaos T. Georgopoulos, Jennifer Southgate, Ludwik K. Trejdosiewicz

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Human urothelial cell carcinoma evolves via the accumulation of numerous genetic alterations, with loss of p53 and p16 function representing important stages in the development of superficial lesions and their progression to malignant disease. To investigate the effects of disabling either or both proteins in otherwise normal human urothelial cells, we performed retroviral transductions with a dominant negative p53 miniprotein and/or mutant cyclin-dependent kinase 4 (CDK4R24C) in 3 independent cell lines. Although cells with disabled p53 function showed a higher proliferation rate, inactivation of neither p53 nor p16 function resulted in any extension of life span and the double-transductants failed to flourish, demonstrating that further genetic alterations are required to attain an immortalised phenotype. However, CDK4R24C transductants showed a marked increase in apoptotic susceptibility to membrane-presented CD40 ligand, being intermediate between normal cells (nonsusceptible) and transformed cells (highly susceptible). By contrast, loss of p53 function alone only slightly increased the apoptotic susceptibility of urothelial cells. These results demonstrate that loss of p16 function, while insufficient to immortalise urothelial cells, nevertheless renders the cells more vulnerable to apoptosis induced by CD40 ligation.

Original languageEnglish
Pages (from-to)634-639
Number of pages6
JournalInternational Journal of Cancer
Volume116
Issue number4
Early online date11 Apr 2005
DOIs
Publication statusPublished - 10 Sep 2005
Externally publishedYes

Fingerprint

Cyclin-Dependent Kinase 4
CD40 Ligand
Life Expectancy
Ligation
Apoptosis
Carcinoma
Phenotype
Cell Line
Membranes
Proteins

Cite this

Shaw, Nicola J. ; Georgopoulos, Nikolaos T. ; Southgate, Jennifer ; Trejdosiewicz, Ludwik K. / Effects of loss of p53 and p16 function on life span and survival of human urothelial cells. In: International Journal of Cancer. 2005 ; Vol. 116, No. 4. pp. 634-639.
@article{fb4a424902bf447ab8b0711dc4a0bba1,
title = "Effects of loss of p53 and p16 function on life span and survival of human urothelial cells",
abstract = "Human urothelial cell carcinoma evolves via the accumulation of numerous genetic alterations, with loss of p53 and p16 function representing important stages in the development of superficial lesions and their progression to malignant disease. To investigate the effects of disabling either or both proteins in otherwise normal human urothelial cells, we performed retroviral transductions with a dominant negative p53 miniprotein and/or mutant cyclin-dependent kinase 4 (CDK4R24C) in 3 independent cell lines. Although cells with disabled p53 function showed a higher proliferation rate, inactivation of neither p53 nor p16 function resulted in any extension of life span and the double-transductants failed to flourish, demonstrating that further genetic alterations are required to attain an immortalised phenotype. However, CDK4R24C transductants showed a marked increase in apoptotic susceptibility to membrane-presented CD40 ligand, being intermediate between normal cells (nonsusceptible) and transformed cells (highly susceptible). By contrast, loss of p53 function alone only slightly increased the apoptotic susceptibility of urothelial cells. These results demonstrate that loss of p16 function, while insufficient to immortalise urothelial cells, nevertheless renders the cells more vulnerable to apoptosis induced by CD40 ligation.",
keywords = "Apoptosis, Bladder, Cancer, CD40, p16, p53, Urothelium",
author = "Shaw, {Nicola J.} and Georgopoulos, {Nikolaos T.} and Jennifer Southgate and Trejdosiewicz, {Ludwik K.}",
year = "2005",
month = "9",
day = "10",
doi = "10.1002/ijc.21114",
language = "English",
volume = "116",
pages = "634--639",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

Effects of loss of p53 and p16 function on life span and survival of human urothelial cells. / Shaw, Nicola J.; Georgopoulos, Nikolaos T.; Southgate, Jennifer; Trejdosiewicz, Ludwik K.

In: International Journal of Cancer, Vol. 116, No. 4, 10.09.2005, p. 634-639.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of loss of p53 and p16 function on life span and survival of human urothelial cells

AU - Shaw, Nicola J.

AU - Georgopoulos, Nikolaos T.

AU - Southgate, Jennifer

AU - Trejdosiewicz, Ludwik K.

PY - 2005/9/10

Y1 - 2005/9/10

N2 - Human urothelial cell carcinoma evolves via the accumulation of numerous genetic alterations, with loss of p53 and p16 function representing important stages in the development of superficial lesions and their progression to malignant disease. To investigate the effects of disabling either or both proteins in otherwise normal human urothelial cells, we performed retroviral transductions with a dominant negative p53 miniprotein and/or mutant cyclin-dependent kinase 4 (CDK4R24C) in 3 independent cell lines. Although cells with disabled p53 function showed a higher proliferation rate, inactivation of neither p53 nor p16 function resulted in any extension of life span and the double-transductants failed to flourish, demonstrating that further genetic alterations are required to attain an immortalised phenotype. However, CDK4R24C transductants showed a marked increase in apoptotic susceptibility to membrane-presented CD40 ligand, being intermediate between normal cells (nonsusceptible) and transformed cells (highly susceptible). By contrast, loss of p53 function alone only slightly increased the apoptotic susceptibility of urothelial cells. These results demonstrate that loss of p16 function, while insufficient to immortalise urothelial cells, nevertheless renders the cells more vulnerable to apoptosis induced by CD40 ligation.

AB - Human urothelial cell carcinoma evolves via the accumulation of numerous genetic alterations, with loss of p53 and p16 function representing important stages in the development of superficial lesions and their progression to malignant disease. To investigate the effects of disabling either or both proteins in otherwise normal human urothelial cells, we performed retroviral transductions with a dominant negative p53 miniprotein and/or mutant cyclin-dependent kinase 4 (CDK4R24C) in 3 independent cell lines. Although cells with disabled p53 function showed a higher proliferation rate, inactivation of neither p53 nor p16 function resulted in any extension of life span and the double-transductants failed to flourish, demonstrating that further genetic alterations are required to attain an immortalised phenotype. However, CDK4R24C transductants showed a marked increase in apoptotic susceptibility to membrane-presented CD40 ligand, being intermediate between normal cells (nonsusceptible) and transformed cells (highly susceptible). By contrast, loss of p53 function alone only slightly increased the apoptotic susceptibility of urothelial cells. These results demonstrate that loss of p16 function, while insufficient to immortalise urothelial cells, nevertheless renders the cells more vulnerable to apoptosis induced by CD40 ligation.

KW - Apoptosis

KW - Bladder

KW - Cancer

KW - CD40

KW - p16

KW - p53

KW - Urothelium

UR - http://www.scopus.com/inward/record.url?scp=23244459839&partnerID=8YFLogxK

U2 - 10.1002/ijc.21114

DO - 10.1002/ijc.21114

M3 - Article

C2 - 15825166

AN - SCOPUS:23244459839

VL - 116

SP - 634

EP - 639

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -